申请人:MERCK PATENT GMBH
公开号:US20160002242A1
公开(公告)日:2016-01-07
Compounds of the formula I
in which X, R
1
and R
2
have the meanings indicated in Claim
1,
are inhibitors of GCN2, and can be employed, inter alia, for the treatment of cancer.
公式I中的化合物,其中X,R1和R2具有声明1中指定的含义,是GCN2的抑制剂,可用于治疗癌症等方面。